Please, Signup (Login) to subscribe or trade (demo)
Pfizer stock price, PFE
Pfizer stock chart:
Pfizer close price: 34
Stock price forecast:
DOWN TO -2.00%
Total forecasts: 90
Reached: 39 (43.33%)
Total Win: 18.40 (57.10%)
Showing 1-10 of 530 items.
|Date of Forecast||Stock Price||Target Price||Forecast Reached Date|
Pfizer latest news:
Momenta Pharma shares halted as drug application hits speed bump
Momenta Pharmaceuticals Inc. were halted in the extended session Friday after the biotech company said a supplier's compliance issue could delay approval of a higher dose of one of its multiple sclerosis drugs. Momenta shares were halted at $19 after hours. The company said a key supplier of its Glatopa multiple sclerosis drug, Pfizer Inc. , was served with a Food and Drug Administration Warning Letter, meaning something at the Pfizer facility was not in compliance with FDA code. Until the facility demonstrates compliance, Momenta said that approval for its marketing application for a 40 mg. dose of Glatopa is "unlikely" in the first quarter. Pfizer shares declined 0.4% to $33.48 after hours.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Pfizer Swings to 4Q Profit After Rough Year, Hikes 2017 View
Drugmaker Pfizer Inc. is forecasting slightly higher sales and profit this year after a difficult 2016, though reduced spending on overhead and lawsuits helped it swing to a fourth-quarter profit, following a loss a year earlier
Pfizer 4Q Profit Misses Estimates
Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.
Philip Morris International IncPM
Philippine Long Distance Telephone CompanyPHI
Phillips 66 Partners LPPSXP
Phoenix New Media LimitedFENG
Physicians Realty TrustDOC